GSK PLC (GSK)
Clinical trial NCT06433921 updates: 1. completion date: 2026-11-06 → 2027-02-26 2. primary completion date: 2026-10-30 → 2027-02-26
Clinical trial NCT06433921 updates: 1. completion date: 2026-11-06 → 2027-02-26 2. primary completion date: 2026-10-30 → 2027-02-26
📉 **NEGATIVE** • Low confidence analysis (52%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical